PROM1 and hepatocellular carcinoma: High expression of CD133 could be detected in 19/67 (28.36%) primary HCC tissues, with 8/36 (22.22%) in stage I, 11/31 (35.48%) in stage II and III and 13/26 (50.00%) in the lung metastasis stage (Fig. 1B).